miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK
Background. Hepatocellular carcinoma (HCC) is one of the most prevalent cancers, and its incidence rate is increasing worldwide. At present, there is no ideal treatment for HCC. In recent years, molecular-targeted therapy has shown significant therapeutic benefits for patients. Ferroptosis is a moda...
Saved in:
| Main Authors: | Zongqiang Hu, Laibang Li, Ma Li, Xibing Zhang, Yu Zhang, Jianghua Ran, Li Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2023/8929525 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway
by: Chunchen Wu, et al.
Published: (2022-01-01) -
MiR-485-3p/MELK cascade mediates tumor progression in pancreatic cancer
by: Yishan Huang, et al.
Published: (2025-05-01) -
MiR-103-3p regulates chondrocyte autophagy, apoptosis, and ECM degradation through the PI3K/Akt/mTOR pathway by targeting CPEB3
by: Jun Li, et al.
Published: (2025-03-01) -
Digoxigenin activates autophagy in hepatocellular carcinoma cells by regulating the PI3K/AKT/mTOR pathway
by: Mengqing Ma, et al.
Published: (2024-12-01) -
TSC complex decrease the expression of mTOR by regulated miR-199b-3p
by: Na Zhao, et al.
Published: (2025-01-01)